STREAMEX CORP. Business Acquisition, Pro Forma Net Income (Loss)
STREAMEX CORP. (STEX) reported Business Acquisition, Pro Forma Net Income (Loss) of -$464.89 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2026-03-31
- STREAMEX CORP. business acquisition, pro forma net income (loss) for the quarter ending 2025-12-31 was -$422.79M.
- STREAMEX CORP. business acquisition, pro forma net income (loss) for the quarter ending 2025-09-30 was -$16.32M.
- STREAMEX CORP. business acquisition, pro forma net income (loss) for the quarter ending 2025-06-30 was -$13.99M.
- STREAMEX CORP. business acquisition, pro forma net income (loss) for the quarter ending 2025-03-31 was -$11.78M.
- STREAMEX CORP. business acquisition, pro forma net income (loss) for fiscal 2025 was -$464.89M.
- STREAMEX CORP. business acquisition, pro forma net income (loss) for fiscal 2024 was -$21.06M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$422.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$439.12M derived: sum of 2 quarters · filed 2026-03-31 | -$453.11M derived: sum of 3 quarters · filed 2026-03-31 | -$464.89M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$16.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$30.32M derived: sum of 2 quarters · filed 2025-11-14 | -$42.10M 10-Q · filed 2025-11-14 | -$42.40M derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-06-30 | -$13.99M 10-Q · filed 2025-08-15 | -$25.77M 10-Q · filed 2025-08-15 | -$26.08M derived: sum of 3 quarters · filed 2026-03-31 | -$30.12M derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-03-31 | -$11.78M derived: 10-K 12 month − 3 quarters · filed 2026-03-31 | -$12.09M derived: sum of 2 quarters · filed 2026-03-31 | -$16.13M derived: sum of 3 quarters · filed 2026-03-31 | -$29.49M derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-12-31 | -$306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$4.34M derived: sum of 2 quarters · filed 2026-03-31 | -$17.71M derived: sum of 3 quarters · filed 2026-03-31 | -$21.06M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$4.04M 10-Q · filed 2025-11-14 | -$17.40M derived: sum of 2 quarters · filed 2025-11-14 | -$20.75M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$13.37M 10-Q · filed 2025-08-15 | -$16.78M 10-Q · filed 2025-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |